Search tips
Search criteria 


Logo of plosonePLoS OneView this ArticleSubmit to PLoSGet E-mail AlertsContact UsPublic Library of Science (PLoS)
PLoS One. 2010; 5(11): 10.1371/annotation/00a3b22e-36a9-4d51-89e5-1e6561e7a1e9.
Published online 2010 November 3. doi:  10.1371/annotation/00a3b22e-36a9-4d51-89e5-1e6561e7a1e9
PMCID: PMC2975020

Correction: Changes in Human Langerhans Cells Following Intradermal Injection of Influenza Virus-Like Particle Vaccines

The following information was missing from the Competing Interests section: SMK, RWC, and Emory University have equity interests in Zetra Biologicals, which is developing virus-like particle technology under license from Emory University. The authors state that this does not alter their adherence to all the PLoS ONE policies on sharing data and materials.


Competing Interests: No competing interests declared.

Articles from PLoS ONE are provided here courtesy of Public Library of Science